Business Model

Development and marketing of CATUVAB® in Europe will be carried out by Lindis Blood Care. We are actively looking for international licensing partners to support our efforts outside of Europe.

Interested parties are welcome to contact us through our website.

Revolutionizing
blood management
for cancer surgery

CATUVAB® – a new MEDICAL DEVICE to remove cancer cells reliably from intraoperative blood during IBS

Contact Us